Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PBI-200 |
Trade Name | |
Synonyms | PBI 200|PBI200 |
Drug Descriptions |
PBI-200 is a pan-NTRK inhibitor with activity against resistance mutations, which potentially reduces tumor cell proliferation and tumor growth (Cancer Res 2019;79(13 Suppl):Abstract nr 2198). |
DrugClasses | Trk Receptor Inhibitor (Pan) 33 |
CAS Registry Number | NA |
NCIT ID | C180857 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PBI-200 | PBI-200 | 0 | 1 |